Blood-based biomarkers for Alzheimer's disease

Chohan, Pruyanka, Dashwood, Mark, Theodoulou, George, Reed, Hannah and Kuruvilla, Tarun (2022) Blood-based biomarkers for Alzheimer's disease. Progress in Neurology and Psychiatry, 26 (4). pp. 10-14. doi:10.1002/pnp.764

Full text not available from this repository.

Abstract

Blood-based biomarkers for identifying Alzheimer's disease (AD) pathology have been of considerable interest over the past decade and can offer a significant advantage over the currently available and validated cerebrospinal fluid and positron emission tomography biomarkers in terms of cost, invasiveness and accessibility. This review explores the role of three blood-based biomarkers; plasma amyloid beta, tau and neurofilament light chain, and their combination, in the identification of AD pathology and how they may be utilised in clinical practice.

Item Type:	Article
Article Type:	Article
Uncontrolled Keywords:	Mild cognitive impairment; Amyloid-beta-peptide; Plasma; Association; Diagnosis; Alzheimer's disease
Subjects:	R Medicine > RC Internal medicine > RC321 Neuroscience. Biological psychiatry. Neuropsychiatry > RC346 Neurology. Diseases of the nervous system
Divisions:	Schools and Research Institutes > School of Health
Depositing User:	Susan Turner
Date Deposited:	24 Nov 2022 09:46
Last Modified:	24 Nov 2022 09:46
URI:	https://eprints.glos.ac.uk/id/eprint/11883

University Staff: Request a correction | Repository Editors: Update this record